IceCure Medical Ltd.
Nasdaq: ICCM
- Raised $17 million (2026)
- 6 clinical trials, 2 active
- FDA-cleared or approved devices
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Repligen Corp
Nasdaq: RGEN
- Raised $48 million (2019)
- 6 clinical trials
- Research grants: $1.2 million
TriSalus Life Sciences, Inc.
Nasdaq: TLSI
- Raised $22 million (2025)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2010
Lucira Health, Inc.
- Raised $33 million (2020)
- 3 clinical trials
- Research grants: $12 million
CapsoVision, Inc
Nasdaq: CV
- Raised $65 million (2024)
- 7 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2005
Xencor Inc
Nasdaq: XNCR
- Raised $25 million (2021)
- 30 clinical trials, 8 active
- Research grants: $199,000
- Founded 2004
Peca Labs, Inc.
- Raised $2.7 million (2025)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
- Research grants: $2.9 million
Acadia Pharmaceuticals Inc
Nasdaq: ACAD
- Raised $86 million (2013)
- 41 clinical trials, 6 active
- Research grants: $1.6 million
Merck & Co., Inc.
NYSE: MRK
- 2546 clinical trials, 348 active
- 1 FDA-registered device site
- 8 FDA-registered drug sites
Virtuoso Surgical, Inc.
- Raised $2.9 million (2026)
- 1 clinical trial, 1 active
- Research grants: $11 million
- Founded 2016
Cynosure Inc
- 52 clinical trials
- FDA-cleared or approved devices
- Research grants: $1.4 million
Syntr Health Technologies, INC
- Raised $795,000 (2022)
- 3 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $6.1 million
TELA Bio, Inc.
Nasdaq: TELA
- Raised $11 million (2019)
- 5 clinical trials, 4 active
- FDA-cleared or approved devices
- Founded 2012
Opko Health, Inc.
Nasdaq: OPK
- Raised $175 million (2013)
- 50 clinical trials, 2 active
- FDA-cleared or approved devices
Macrogenics Inc
Nasdaq: MGNX
- Raised $12 million (2011)
- 43 clinical trials, 5 active
- Research grants: $2.6 million
Sight Sciences, Inc.
Nasdaq: SGHT
- Raised $23 million (2020)
- 17 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2010
Neurolutions Inc
- Raised $27 million (2025)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $3.9 million
Potrero Medical, Inc.
- Raised $6.5 million (2026)
- 7 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $5.8 million
Emergent BioSolutions Inc.
NYSE: EBS
- Raised $48 million (2018)
- 61 clinical trials, 7 active
- 2 FDA-registered drug sites
Vistagen Therapeutics, Inc.
Nasdaq: VTGN
- Raised $2.8 million (2020)
- 11 clinical trials, 3 active
- Research grants: $7.2 million
Showing 160 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences